January 2018 | Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm AG on the acquisition of 100% of the shares in Trommsdorff from Grupo Ferrer. |
|
|
September 2023 |
Murnauer Markenvertrieb GmbH, a portfolio company of Bregal Unternehmerkapital |
Healthcare |
FERBER & CO. advised Murnauer Markenvertrieb GmbH, a portfolio company of Bregal Unternehmerkapital, on the sale of its pharmacy brand portfolio consisting of "DermaSel", "Murnauer's Bachblüten" as well as the CBD gels "Cannaren" and "Cannaxil" to Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung. |
|
March 2023 |
FR L'Osteria SE and its shareholders |
Consumer Goods and Retail |
FERBER & CO. advised FR L'Osteria SE and its shareholders on the sale of a majority stake to McWin Partners.
|
|
January 2023 |
Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm on the acquisition of Arkopharma SE from Montagu Private Equity LLP. |
|
December 2022 |
Apurano Pharmaceuticals |
Healthcare |
FERBER & CO. advised Apurano Pharmaceuticals on the realignment of its shareholder base including expansion funding round. |
|
February 2022 |
Vitafy Brands and its shareholders |
Healthcare |
FERBER & CO. advised Vitafy Brands and its shareholders on the merger with EVP Group. |
|
January 2022 |
Dermapharm AG |
Healthcare |
FERBER & CO. advised Dermapharm on the acquisition of C3 - Cannabinoid Compound Company GmbH from Canopy Growth Corporation. |
|
January 2022 |
Dermazentrum and its founder |
Healthcare |
FERBER & Co. advised Dermazentrum and its founder on the sale of a majority ownership stake in an Owners Buy-out to Halder. |
|
June 2021 |
Wellster Healthtech |
Healthcare |
FERBER & CO. advised and supported Wellster Healthtech in its funding round on the successful completion of a USD 40m private placement led by a group of investors. |
|
February 2021 |
Shareholders of teamtechnik Maschinen und Anlagen GmbH |
Industrials and Capital Goods |
FERBER & CO. advised the shareholders of teamtechnik Maschinen und Anlagen GmbH on the sale of a 75% majority interest to Dürr group. |
|
December 2020 |
Permira |
Healthcare |
FERBER & CO. advised Permira on the aquisition of Neuraxpharm from Apax Partners. |
|